Eli Lilly

Eli Lilly puts up $100M for 5-target deal with China's InnoCare

Lilly has committed $100 million in upfront and near-term payments, plus up to $3.25 billion in milestones, to form a five-target drug discovery pact.

Nick Paul Taylor Sep 24, 2026 2:39am

DPHARM: How to address the clinical trial enrollment crisis?

Sep 17, 2026 11:52am

Lilly pledges up to $237M per program in CNS genetic med collab

Sep 15, 2026 8:42am

Person throwing piece of paper into full waste bin

Lilly cans early obesity drug after ‘high bar’ not met

Sep 14, 2026 12:45pm

Fierce Pharma

No more Nordisk as Novo goes it alone amid rebranding push

Sep 14, 2026 6:54am

Kura creates Lilly-backed spinout in next-gen diabetes play

Sep 9, 2026 10:20am